News
Toronto, Canada, December 17, 2021 — TaperMD Deprescribing Study Protocol Released
TaperMD, maker of a cutting-edge online medication review platform, announced the publication of the Team Approach to Polypharmacy Evaluation and Reduction: Study Protocol for a Randomized Controlled Trial (RCT) in the BMC Trials journal. The article outlines the basis for formal evaluation of TaperMD’s platform in clinical trials to reduce polypharmacy and improve health outcomes. read more …
Toronto, Canada, September 7, 2021 — TaperMD qualifies for Ontario’s New Medications Safety Funding
TaperMD, maker of a cutting-edge online medication review platform announced new collaborative medication review tools as part of new initiatives eligible under Ontario’s Medication Safety Technology funding program for long term care facilities (LTC). read more …
Toronto, Canada, March 1, 2021 — TaperMD Announces Integration with PointClickCare
Helping pharmacists perform better, more efficient medication reviews
TaperMD, maker of a cutting-edge online medication review platform, today announced a technology partnership with PointClickCare, the leader in cloud‐based healthcare software for the long‐term and post‐acute care (LTPAC) market. read more …
Toronto Canada, November 13, 2020 — Launch of PIMsPlus Medication Reference Site